<DOC>
	<DOCNO>NCT00479687</DOCNO>
	<brief_summary>This clinical trial determine safety effectiveness three injection SUPARTZ ( sodium hyaluronate ) compare saline ( placebo ) treatment glenohumeral osteoarthritis shoulder . The trial contain two phase . In first phase subject randomize either SUPARTZ placebo treatment . The second phase trial open-label subject receive SUPARTZ injection .</brief_summary>
	<brief_title>SUPARTZ Versus Placebo Osteoarthritis Shoulder</brief_title>
	<detailed_description>Phase III Multi-center , randomize study determine safety efficacy injection SUPARTZ Osteoarthritis Shoulder</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Glenohumeral OA confirm radiograph Limitation shoulder motion least one direction Full thickness rotator cuff tear rotator cuff tendonopathy Frozen shoulder Female pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Shoulder</keyword>
	<keyword>HA</keyword>
</DOC>